$BCRX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in BIOCRYST PHARMACEUTICALS INC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in BIOCRYST PHARMACEUTICALS INC. Get notifications about new insider transactions in BIOCRYST PHARMACEUTICALS INC for free.

Page: < prev 1 2 3 4 5 6 7 ... 9 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 22 2018	BCRX	BIOCRYST PHARMACEU ...	INGRAM ROBERT ALEXANDER	Director	Option Exercise	A	6.09	30,000	182,700	30,000
Jun 22 2018	BCRX	BIOCRYST PHARMACEU ...	Hutson Nancy J	Director	Option Exercise	A	6.09	30,000	182,700	30,000
Jun 22 2018	BCRX	BIOCRYST PHARMACEU ...	Erck Stanley C	Director	Option Exercise	A	6.09	30,000	182,700	30,000
Jun 22 2018	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Option Exercise	A	6.09	30,000	182,700	30,000
Jun 22 2018	BCRX	BIOCRYST PHARMACEU ...	ABERCROMBIE GEORGE B	Director	Option Exercise	A	6.09	30,000	182,700	30,000
Jun 05 2018	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Option Exercise	M	2.58	42,112	108,649	0
Jun 05 2018	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Sell	S	6.30	42,112	265,306	21,058	63.2 K to 21.1 K (-66.66 %)
Jun 05 2018	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Buy	M	2.58	42,112	108,649	63,170	21.1 K to 63.2 K (+199.98 %)
Jun 04 2018	BCRX	BIOCRYST PHARMACEU ...	INGRAM ROBERT ALEXANDER	Director	Grant	A	6.43	2,916	18,750	21,818	18.9 K to 21.8 K (+15.43 %)
Jun 04 2018	BCRX	BIOCRYST PHARMACEU ...	INGRAM ROBERT ALEXANDER	Director	Grant	A	6.43	2,916	18,750	21,818	18.9 K to 21.8 K (+15.43 %)
Jun 04 2018	BCRX	BIOCRYST PHARMACEU ...	Hutson Nancy J	Director	Grant	A	6.43	1,555	9,999	39,702	38.1 K to 39.7 K (+4.08 %)
May 21 2018	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Option Exercise	M	1.42	70,427	100,006	297,573
May 21 2018	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Buy	M	1.42	70,427	100,006	725,519	655.1 K to 725.5 K (+10.75 %)
May 17 2018	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	VP, General Counsel ...	Option Exercise	M	1.42	12,500	17,750	8,132
May 17 2018	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	VP, General Counsel ...	Payment of Exercise	F	5.91	3,004	17,754	95,264	98.3 K to 95.3 K (-3.06 %)
May 17 2018	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	VP, General Counsel ...	Buy	M	1.42	12,500	17,750	98,268	85.8 K to 98.3 K (+14.57 %)
Mar 08 2018	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Option Exercise	M	3.26	9,378	30,572	0
Mar 08 2018	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Option Exercise	M	3.26	20,622	67,228	0
Mar 08 2018	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Payment of Exercise	F	5.18	5,902	30,572	108,871	114.8 K to 108.9 K (-5.14 %)
Mar 08 2018	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Buy	M	3.26	9,378	30,572	114,773	105.4 K to 114.8 K (+8.90 %)
Mar 08 2018	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Payment of Exercise	F	5.18	15,223	78,855	105,395	120.6 K to 105.4 K (-12.62 %)
Mar 08 2018	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Buy	M	3.26	20,622	67,228	120,618	100 K to 120.6 K (+20.62 %)
Mar 02 2018	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Option Exercise	M	3.26	56,949	185,654	0
Mar 02 2018	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Payment of Exercise	F	4.97	43,224	214,823	655,092	698.3 K to 655.1 K (-6.19 %)
Mar 02 2018	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Buy	M	3.26	56,949	185,654	698,316	641.4 K to 698.3 K (+8.88 %)
Mar 02 2018	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	VP, General Counsel ...	Option Exercise	M	3.26	6,709	21,871	0
Mar 02 2018	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	VP, General Counsel ...	Buy	M	3.26	6,709	21,871	85,768	79.1 K to 85.8 K (+8.49 %)
Mar 02 2018	BCRX	BIOCRYST PHARMACEU ...	INGRAM ROBERT ALEXANDER	Director	Grant	A	4.97	3,772	18,747	18,902	15.1 K to 18.9 K (+24.93 %)
Mar 02 2018	BCRX	BIOCRYST PHARMACEU ...	Hutson Nancy J	Director	Grant	A	4.97	2,012	10,000	38,147	36.1 K to 38.1 K (+5.57 %)
Jan 23 2018	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	VP, General Counsel ...	Payment of Exercise	F	5.59	1,961	10,962	77,129	79.1 K to 77.1 K (-2.48 %)
Jan 23 2018	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Payment of Exercise	F	5.59	3,872	21,644	99,996	103.9 K to 100 K (-3.73 %)
Jan 23 2018	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Payment of Exercise	F	5.59	4,628	25,871	18,058	22.7 K to 18.1 K (-20.40 %)
Jan 23 2018	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Payment of Exercise	F	5.59	3,979	22,243	137,383	141.4 K to 137.4 K (-2.81 %)
Jan 23 2018	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Payment of Exercise	F	5.59	9,584	53,575	638,367	648 K to 638.4 K (-1.48 %)
Jan 03 2018	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	VP, General Counsel ...	Payment of Exercise	F	4.91	459	2,254	79,090	79.5 K to 79.1 K (-0.58 %)
Jan 03 2018	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Payment of Exercise	F	4.91	838	4,115	103,868	104.7 K to 103.9 K (-0.80 %)
Jan 03 2018	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Payment of Exercise	F	4.91	1,169	5,740	22,686	23.9 K to 22.7 K (-4.90 %)
Jan 03 2018	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Payment of Exercise	F	4.91	852	4,183	141,362	142.2 K to 141.4 K (-0.60 %)
Jan 03 2018	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Payment of Exercise	F	4.91	2,716	13,336	647,951	650.7 K to 648 K (-0.42 %)
Dec 22 2017	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	VP, General Counsel ...	Option Exercise	A	5.04	62,500	315,000	62,500
Dec 22 2017	BCRX	BIOCRYST PHARMACEU ...	Powell Lynne	Senior VP - CCO	Option Exercise	A	5.04	80,000	403,200	80,000
Dec 22 2017	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Option Exercise	A	5.04	100,000	504,000	100,000
Dec 22 2017	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Option Exercise	A	5.04	100,000	504,000	100,000
Dec 22 2017	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	A	5.04	100,000	504,000	100,000
Dec 22 2017	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Option Exercise	A	5.04	300,000	1,512,000	300,000
Dec 04 2017	BCRX	BIOCRYST PHARMACEU ...	INGRAM ROBERT ALEXANDER	Director	Grant	A	5.08	3,690	18,745	15,130	11.4 K to 15.1 K (+32.26 %)
Dec 04 2017	BCRX	BIOCRYST PHARMACEU ...	Hutson Nancy J	Director	Grant	A	5.08	1,968	9,997	36,135	34.2 K to 36.1 K (+5.76 %)
Nov 15 2017	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Sell	S	4.72	64,310	303,543	23,855	88.2 K to 23.9 K (-72.94 %)
Sep 20 2017	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Option Exercise	M	4.27	54,250	231,648	0
Sep 20 2017	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Sell	S	5.42	54,250	294,035	119,410	173.7 K to 119.4 K (-31.24 %)
Sep 20 2017	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Buy	M	4.27	54,250	231,648	173,660	119.4 K to 173.7 K (+45.43 %)
Sep 05 2017	BCRX	BIOCRYST PHARMACEU ...	Powell Lynne	Senior VP - CCO	Option Exercise	A	11.33	30,000	339,900	30,000
Sep 05 2017	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	VP, General Counsel ...	Option Exercise	A	11.13	18,600	207,018	18,600
Sep 05 2017	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Option Exercise	A	11.13	33,900	377,307	33,900
Sep 05 2017	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Option Exercise	A	11.13	27,000	300,510	27,000
Sep 05 2017	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	A	11.13	27,000	300,510	27,000
Sep 05 2017	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Option Exercise	A	12.16	40,710	495,034	40,710
Sep 05 2017	BCRX	BIOCRYST PHARMACEU ...	INGRAM ROBERT ALEXANDER	Director	Grant	A	5.10	3,676	18,748	11,440	7.8 K to 11.4 K (+47.35 %)
Sep 05 2017	BCRX	BIOCRYST PHARMACEU ...	Hutson Nancy J	Director	Grant	A	5.10	1,960	9,996	34,167	32.2 K to 34.2 K (+6.09 %)
Jun 02 2017	BCRX	BIOCRYST PHARMACEU ...	INGRAM ROBERT ALEXANDER	Director	Grant	A	5.15	1,941	9,996	7,764	5.8 K to 7.8 K (+33.33 %)
Jun 02 2017	BCRX	BIOCRYST PHARMACEU ...	Hutson Nancy J	Director	Grant	A	5.15	1,941	9,996	32,207	30.3 K to 32.2 K (+6.41 %)
Jun 02 2017	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Grant	A	5.15	1,941	9,996	119,410	117.5 K to 119.4 K (+1.65 %)
May 25 2017	BCRX	BIOCRYST PHARMACEU ...	Patel Sanj K	Director	Option Exercise	A	5.13	30,000	153,900	30,000
May 25 2017	BCRX	BIOCRYST PHARMACEU ...	LEE KENNETH B JR	Director	Option Exercise	A	5.13	30,000	153,900	30,000
May 25 2017	BCRX	BIOCRYST PHARMACEU ...	INGRAM ROBERT ALEXANDER	Director	Option Exercise	A	5.13	30,000	153,900	30,000
May 25 2017	BCRX	BIOCRYST PHARMACEU ...	Hutson Nancy J	Director	Option Exercise	A	5.13	30,000	153,900	30,000
May 25 2017	BCRX	BIOCRYST PHARMACEU ...	Erck Stanley C	Director	Option Exercise	A	5.13	30,000	153,900	30,000
May 25 2017	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Option Exercise	A	5.13	30,000	153,900	30,000
May 25 2017	BCRX	BIOCRYST PHARMACEU ...	ABERCROMBIE GEORGE B	Director	Option Exercise	A	5.13	30,000	153,900	30,000
May 24 2017	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	M	4.73	7,750	36,658	4,000
May 24 2017	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Payment of Exercise	F	5.24	6,996	36,659	142,214	149.2 K to 142.2 K (-4.69 %)
May 24 2017	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Buy	M	4.73	7,750	36,658	149,210	141.5 K to 149.2 K (+5.48 %)
Mar 22 2017	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	M	3.78	3,250	12,285	55,805
Mar 22 2017	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	9.20	3,250	29,900	141,460	144.7 K to 141.5 K (-2.25 %)
Mar 22 2017	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Buy	M	3.78	3,250	12,285	144,710	141.5 K to 144.7 K (+2.30 %)
Mar 20 2017	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	M	1.42	12,500	17,750	75,000
Mar 20 2017	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	M	3.78	23,955	90,550	59,055
Mar 20 2017	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Payment of Exercise	F	8.80	12,308	108,310	141,460	153.8 K to 141.5 K (-8.00 %)
Mar 20 2017	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Buy	M	1.42	12,500	17,750	153,768	141.3 K to 153.8 K (+8.85 %)
Mar 20 2017	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Buy	M	3.78	23,955	90,550	141,268	117.3 K to 141.3 K (+20.42 %)
Mar 14 2017	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	M	3.78	3,250	12,285	83,010
Mar 14 2017	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	9.06	3,250	29,445	117,313	120.6 K to 117.3 K (-2.70 %)
Mar 14 2017	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Buy	M	3.78	3,250	12,285	120,563	117.3 K to 120.6 K (+2.77 %)
Mar 10 2017	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	M	3.78	6,500	24,570	86,260
Mar 10 2017	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	8.65	3,250	28,113	117,313	120.6 K to 117.3 K (-2.70 %)
Mar 10 2017	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	8.20	3,250	26,650	120,563	123.8 K to 120.6 K (-2.62 %)
Mar 10 2017	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Buy	M	3.78	6,500	24,570	123,813	117.3 K to 123.8 K (+5.54 %)
Mar 08 2017	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	M	3.78	3,250	12,285	92,760
Mar 08 2017	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	7.90	3,250	25,675	117,313	120.6 K to 117.3 K (-2.70 %)
Mar 08 2017	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Buy	M	3.78	3,250	12,285	120,563	117.3 K to 120.6 K (+2.77 %)
Mar 02 2017	BCRX	BIOCRYST PHARMACEU ...	INGRAM ROBERT ALEXANDER	Director	Grant	A	6.24	1,602	9,996	5,823	4.2 K to 5.8 K (+37.95 %)
Mar 02 2017	BCRX	BIOCRYST PHARMACEU ...	Hutson Nancy J	Director	Grant	A	6.24	1,602	9,996	30,266	28.7 K to 30.3 K (+5.59 %)
Mar 02 2017	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Grant	A	6.24	1,602	9,996	117,469	115.9 K to 117.5 K (+1.38 %)
Mar 01 2017	BCRX	BIOCRYST PHARMACEU ...	Powell Lynne	Senior VP - CCO	Option Exercise	A	5.51	150,000	826,500	150,000
Mar 01 2017	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	VP, General Counsel ...	Option Exercise	A	5.51	150,000	826,500	150,000
Mar 01 2017	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Option Exercise	A	5.51	175,000	964,250	175,000
Mar 01 2017	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Option Exercise	A	5.51	175,000	964,250	175,000
Mar 01 2017	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	A	5.51	175,000	964,250	175,000
Mar 01 2017	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Option Exercise	A	5.51	500,000	2,755,000	500,000
Jan 24 2017	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	VP, General Counsel ...	Payment of Exercise	F	5.95	2,599	15,464	75,497	78.1 K to 75.5 K (-3.33 %)
Jan 24 2017	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Payment of Exercise	F	5.95	5,083	30,244	104,706	109.8 K to 104.7 K (-4.63 %)
Jan 24 2017	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Payment of Exercise	F	5.95	5,761	34,278	82,916	88.7 K to 82.9 K (-6.50 %)
Jan 24 2017	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Payment of Exercise	F	5.95	5,198	30,928	117,313	122.5 K to 117.3 K (-4.24 %)
Jan 24 2017	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Payment of Exercise	F	5.95	10,572	62,903	645,418	656 K to 645.4 K (-1.61 %)
Jan 03 2017	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	VP, General Counsel ...	Payment of Exercise	F	6.33	1,281	8,109	78,096	79.4 K to 78.1 K (-1.61 %)
Jan 03 2017	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Payment of Exercise	F	6.33	1,639	10,375	109,789	111.4 K to 109.8 K (-1.47 %)
Jan 03 2017	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Payment of Exercise	F	6.33	2,081	13,173	88,677	90.8 K to 88.7 K (-2.29 %)
Jan 03 2017	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Payment of Exercise	F	6.33	1,676	10,609	122,511	124.2 K to 122.5 K (-1.35 %)
Jan 03 2017	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Payment of Exercise	F	6.33	8,595	54,406	655,990	664.6 K to 656 K (-1.29 %)
Dec 21 2016	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	M	3.78	3,250	12,285	96,010
Dec 21 2016	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	7.45	3,250	24,213	124,187	127.4 K to 124.2 K (-2.55 %)
Dec 21 2016	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Buy	M	3.78	3,250	12,285	127,437	124.2 K to 127.4 K (+2.62 %)
Dec 02 2016	BCRX	BIOCRYST PHARMACEU ...	INGRAM ROBERT ALEXANDER	Director	Grant	A	5.59	1,788	9,995	4,221	2.4 K to 4.2 K (+73.49 %)
Dec 02 2016	BCRX	BIOCRYST PHARMACEU ...	Hutson Nancy J	Director	Grant	A	5.59	1,788	9,995	28,664	26.9 K to 28.7 K (+6.65 %)
Dec 02 2016	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Grant	A	5.59	1,788	9,995	115,867	114.1 K to 115.9 K (+1.57 %)
Sep 16 2016	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	VP, General Counsel ...	Sell	S	4.27	8,357	35,684	79,377	87.7 K to 79.4 K (-9.53 %)
Sep 06 2016	BCRX	BIOCRYST PHARMACEU ...	INGRAM ROBERT ALEXANDER	Director	Grant	A	4.11	2,433	10,000	2,433	0 to 2.4 K
Sep 06 2016	BCRX	BIOCRYST PHARMACEU ...	Hutson Nancy J	Director	Grant	A	4.11	2,433	10,000	26,876	24.4 K to 26.9 K (+9.95 %)
Sep 06 2016	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Grant	A	4.11	2,433	10,000	114,079	111.6 K to 114.1 K (+2.18 %)
Aug 29 2016	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Sell	S	4.06	30,000	121,800	111,428	141.4 K to 111.4 K (-21.21 %)
Aug 16 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Sell	S	4.29	850	3,645	9,418,390	9.4 M to 9.4 M (-0.01 %)
Aug 16 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Sell	S	4.29	140	600	1,551,387	1.6 M to 1.6 M (-0.01 %)
Aug 16 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Sell	S	4.83	343,583	1,658,681	9,419,240	9.8 M to 9.4 M (-3.52 %)
Aug 16 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Sell	S	4.83	56,417	272,359	1,551,527	1.6 M to 1.6 M (-3.51 %)
Aug 16 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Sell	S	5.25	296,856	1,559,711	9,762,823	10.1 M to 9.8 M (-2.95 %)
Aug 16 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Sell	S	5.25	48,744	256,106	1,607,944	1.7 M to 1.6 M (-2.94 %)
Aug 16 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Sell	S	5.00	2,834,561	14,172,805	10,059,679	12.9 M to 10.1 M (-21.98 %)
Aug 16 2016	BCRX	BIOCRYST PHARMACEU ...	BAKER BROS. ADVISORS LP	10% Owner	Sell	S	5.00	465,439	2,327,195	1,656,688	2.1 M to 1.7 M (-21.93 %)
Aug 15 2016	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	5.22	4,558	23,793	124,187	128.7 K to 124.2 K (-3.54 %)
Aug 15 2016	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	5.05	1,306	6,595	128,745	130.1 K to 128.7 K (-1.00 %)
Aug 11 2016	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Sell	S	4.43	14,577	64,576	130,051	144.6 K to 130.1 K (-10.08 %)
Jun 02 2016	BCRX	BIOCRYST PHARMACEU ...	Hutson Nancy J	Director	Grant	A	3.39	2,581	8,750	24,443	21.9 K to 24.4 K (+11.81 %)
Jun 02 2016	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Grant	A	3.39	2,581	8,750	111,646	109.1 K to 111.6 K (+2.37 %)
May 25 2016	BCRX	BIOCRYST PHARMACEU ...	Powell Lynne	Senior VP - CCO	Option Exercise	A	3.22	129,427	416,755	129,427
May 25 2016	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	VP, General Counsel ...	Option Exercise	A	3.22	91,004	293,033	91,004
May 25 2016	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Option Exercise	A	3.22	129,427	416,755	129,427
May 25 2016	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Option Exercise	A	3.22	148,302	477,532	148,302
May 25 2016	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Option Exercise	A	3.22	129,427	416,755	129,427
May 25 2016	BCRX	BIOCRYST PHARMACEU ...	Stonehouse Jon P	President & CEO	Option Exercise	A	3.22	337,050	1,085,301	337,050
May 25 2016	BCRX	BIOCRYST PHARMACEU ...	Patel Sanj K	Director	Option Exercise	A	3.22	30,000	96,600	30,000
May 25 2016	BCRX	BIOCRYST PHARMACEU ...	LEE KENNETH B JR	Director	Option Exercise	A	3.22	30,000	96,600	30,000
May 25 2016	BCRX	BIOCRYST PHARMACEU ...	INGRAM ROBERT ALEXANDER	Director	Option Exercise	A	3.22	30,000	96,600	30,000
May 25 2016	BCRX	BIOCRYST PHARMACEU ...	Hutson Nancy J	Director	Option Exercise	A	3.22	30,000	96,600	30,000
May 25 2016	BCRX	BIOCRYST PHARMACEU ...	Erck Stanley C	Director	Option Exercise	A	3.22	30,000	96,600	30,000
May 25 2016	BCRX	BIOCRYST PHARMACEU ...	Cohen Fred E	Director	Option Exercise	A	3.22	30,000	96,600	30,000
May 25 2016	BCRX	BIOCRYST PHARMACEU ...	ABERCROMBIE GEORGE B	Director	Option Exercise	A	3.22	30,000	96,600	30,000
Mar 03 2016	BCRX	BIOCRYST PHARMACEU ...	Barnes Alane P	VP, General Counsel ...	Payment of Exercise	F	2.13	687	1,463	85,416	86.1 K to 85.4 K (-0.80 %)
Mar 03 2016	BCRX	BIOCRYST PHARMACEU ...	Babu Yarlagadda S	Senior VP - Drug Di ...	Payment of Exercise	F	2.13	906	1,930	141,428	142.3 K to 141.4 K (-0.64 %)
Mar 03 2016	BCRX	BIOCRYST PHARMACEU ...	Sheridan William P	Senior VP - CMO	Payment of Exercise	F	2.13	799	1,702	90,052	90.9 K to 90.1 K (-0.88 %)
Mar 03 2016	BCRX	BIOCRYST PHARMACEU ...	STAAB THOMAS R II	Senior Vice Preside ...	Payment of Exercise	F	2.13	465	990	144,628	145.1 K to 144.6 K (-0.32 %)

Page: < prev 1 2 3 4 5 6 7 ... 9 next >